DRS vs TECH · P/E 43, rev $3.23B vs P/E 65, rev $1.22B
Leonardo DRS, Inc. Common Stock (DRS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Leonardo DRS, Inc. Common Stock (DRS) is a aerospace & defense company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DRS revenue for 2024-12-31 was $3.23B. Net income was $213.0M. Revenue was up 14.4% from 2023-12-31 to 2024-12-31. DRS currently screens at market cap $12.31B and trailing P/E 43.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DRS currently screens at market cap $12.31B and trailing P/E 43.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DRS and TECH stock pages for the full models.
Not investment advice.